ELI LILLY & Co is 624.2x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($1.072 T vs $1.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AGIO | LLY |
|---|---|---|
| Market cap | $1.72 B | $1.072 T |
| US-listed rank | #2208 | #10 |
| Revenue (latest FY) | $54.03M | $65.18B |
| Net income (latest FY) | -$413.00M | $20.64B |
| Net margin | -764.4% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 1,268 | 989 |
ELI LILLY & Co is 624.2x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($1.072 T vs $1.72 B).
In their latest fiscal years, AGIOS PHARMACEUTICALS, INC. reported $54.03M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: AGIOS PHARMACEUTICALS, INC. and ELI LILLY & Co, or browse the full rankings.